United Therapeutics (NASDAQ:UTHR) reported its Q1 earnings results on Wednesday, May 3, 2023 at 06:00 AM.
Here’s what investors need to know about the announcement.
Earnings
United Therapeutics beat estimated earnings by 7.52%, reporting an EPS of $4.86 versus an estimate of $4.52.
Revenue was up $45.00 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.84 which was followed by a 1.89% increase in the share price the next day.
Here’s a look at United Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 4.51 | 3.89 | 4.12 | 3.34 |
| EPS Actual | 2.67 | 4.91 | 2.41 | 5.03 |
| Revenue Estimate | 519.21M | 493.20M | 461.06M | 420.02M |
| Revenue Actual | 491.50M | 516.00M | 466.90M | 461.90M |
To track all earnings releases for United Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
